Results 161 to 170 of about 48,587,327 (320)

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Study validity

open access: yesThe Journal of Indian Prosthodontic Society, 2018
openaire   +3 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Systematic profiling of conditional degron tag technologies for target validation studies. [PDF]

open access: yesNat Commun, 2022
Bondeson DP   +18 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Adaptação transcultural para o português do End of Life Comfort Questionnaire – Patient [Cross-cultural adaptation of the End of Life Comfort Questionnaire-Patient to Brazilian Portuguese]

open access: yesRevista Enfermagem UERJ, 2014
O objetivo foi validar para o português, falado no Brasil, a escala End of life Comfort Questionnaire-Patient. A validação constituiu-se de tradução, síntese, retrotradução, revisão por comitê de especialistas, pré-teste e verificação das propriedades ...
Liana Amorim Corrêa Trotte   +4 more
doaj  

Assessment of 24-hour physical behaviour in adults via wearables: a systematic review of validation studies under laboratory conditions. [PDF]

open access: yesInt J Behav Nutr Phys Act, 2023
Giurgiu M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy